The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws
Researchers at City...
Juniper® Apstra® selected to simplify operations, streamline costs and improve user experience with Intent-Based Networking
Juniper Networks, a leader in secure, AI-driven networks, and NEC Corporation,...
Tempus, a leader in artificial intelligence and precision medicine, announced xF Monitor – a new circulating tumor DNA (ctDNA) assay for research use only,...
Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, announced the commercial release of its BioXp® De novo Cloning and Amplification...
TSO 500 ctDNA Version 2 delivers faster turnaround time, greater analytical sensitivity, more streamlined workflow, further enabling precision medicine.
Illumina Inc., a global leader in...